The study titled, Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up: A Target Trial Emulation, was published today in Annals of Internal Medicine:

Abstract

Background:

Monovalent COVID-19 vaccines targeting the XBB.1.5 Omicron variant were introduced in September

The post BREAKING: Sixth Study Confirms Negative Efficacy of COVID-19 mRNA Injections appeared first on Global Research.

Leave A Comment